CBIO Market Cap & Key Metrics
Crescent Biopharma, Inc.
$14.76
+$0.84(+6.00%)
32
Overall
40
Value
30
Tech
28
Quality
Market Cap
$548.06M
Volume
269.52K
52W Range
$8.72 - $27.41
Target Price
$32.00
CBIO market cap is $548.06M. This page lists Crescent Biopharma, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CBIO Key Metrics
- Market cap
- $548.06M
- EPS estimate, current year
- $-2.93
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 28
- Technical score
- 30
| Fiscal year | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | - | - | $18.5K | $20.07M | $15.03M |
| EBITDA | -$48.00M | -$33.02M | -$31.62M | -$12.58M | -$10.96M |
| EPS | - | - | - | $-47.00 | $-60.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CBIO | $14.76 | +6.0% | 269.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crescent Biopharma, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW